Is Obesity a Problem in New Cystic Fibrosis Treatments?
CF patients treated with triple therapy experience significant weight gain, increasing the proportion of overweight patients. CF patients who experienced greater weight gain were those with worse BMI at the start of treatment, as well as patients with worse lung function and a greater number of exacerbations in the year before starting ETI therapy.
Authors
- Claudia Janeth Madrid-Carbajal (ORCID: https://orcid.org/0000-0002-2112-1958)
- Marta García‐Clemente (ORCID: https://orcid.org/0000-0003-0463-5946)
- Rosa Mar Gómez Punter
- Marta Solís-García
- Adrián Peláez (ORCID: https://orcid.org/0000-0003-0284-6643)
- Rosa Girón (ORCID: https://orcid.org/0000-0001-7094-0848)
- José María Eiros Bachiller
Institutions
- Universidad de Oviedo (ES)
- HM Hospitales (ES)
- Hospital Universitario de La Princesa (ES)
- Hospital Universitario Central de Asturias (ES)
- Instituto de Investigación Sanitaria del Principado de Asturias (ES)
- Camilo José Cela University (ES)
Publication Details
- Journal
- Nutrients
- Published
- 2024-09-14
- DOI
- https://doi.org/10.3390/nu16183103
- Citations
- 9
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 3.77